Impact of histamine type-2 receptor antagonists on the anticancer efficacy of gefitinib in patients with non-small cell lung cancer.
Yoshitaka SaitoYoh TakekumaMasaki KobayashiNaofumi ShinagawaYasushi ShimizuIchiro KinoshitaHirotoshi Dosaka-AkitaKen IsekiMitsuru SugawaraPublished in: European journal of clinical pharmacology (2020)
This study demonstrated that concomitant administration of H2RA with gefitinib does not affect the efficacy of gefitinib.